Advertisement

Topics

ViewRay Incorporated Company Profile

01:05 EST 25th November 2017 | BioPortfolio

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patient in three dimensions during radiation therapy delivery. This real time imaging will control the delivery of the radiation therapy and record the dose delivered to the patient, allowing physicians to potentially reduce side effects and improve cure rates. For further information please see www.viewray.com.


News Articles [20 Associated News Articles listed on BioPortfolio]

ViewRay® to Participate in Morgan Stanley Global Healthcare Conference

CLEVELAND, Sept. 6, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer are scheduled to participate ...

ViewRay® to Host Analyst & Investor Meeting at ASTRO in San Diego

CLEVELAND, Sept. 20, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investors on Monday, September 25, 2017, during t...

ViewRay nets $49.9mm through registered direct offering

ViewRay Inc. (MRI-guided radiation) netted $49.9mm through a registered direct offering to new and existing investors of 8.4mm common shares at $5.95, a 5% discount. (Affiliates of the company also pu...

Early data shows nearly 2x prolonged median survival for inoperable pancreatic cancer

(ViewRay) A retrospective review of 42 inoperable, locally-advanced pancreatic cancer patients treated at four institutions found that higher delivered radiation doses enabled via ViewRay's MRIdian ad...

Viewray Powers Up

ViewRay Expands Across The World

Major Institutional Investors Buy ViewRay Stock

ViewRay's (VRAY) CEO Chris Raanes on Q2 2017 Results - Earnings Call Transcript

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Methods to model and predict the ViewRay treatment deliveries to aid patient scheduling and treatment planning.

A software tool is developed, given a new treatment plan, to predict treatment delivery time for radiation therapy (RT) treatments of patients on ViewRay magnetic resonance image-guided radiation ther...

Development of a 3D remote dosimetry protocol compatible with MRgIMRT.

To develop a novel remote 3D dosimetry protocol to verify Magnetic Resonance-guided Radiation Therapy (MRgRT) treatments. The protocol was applied to investigate the accuracy of TG-119 IMRT irradiatio...

A comparative study of automatic image segmentation algorithms for target tracking in MR-IGRT.

On-board magnetic resonance (MR) image guidance during radiation therapy offers the potential for more accurate treatment delivery. To utilize the real-time image information, a crucial prerequisite i...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

MRI Adaptive Replanning Using ViewRay

Current dose escalation regimens with and without chemotherapy have failed to achieve improved local control and overall survival over standard of care therapy to date. Difficulties with d...

Companies [38 Associated Companies listed on BioPortfolio]

ViewRay, Inc.

ViewRay, Inc., of Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay s...

ViewRay Incorporated

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "ViewRay Incorporated" on BioPortfolio

We have published hundreds of ViewRay Incorporated news stories on BioPortfolio along with dozens of ViewRay Incorporated Clinical Trials and PubMed Articles about ViewRay Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ViewRay Incorporated Companies in our database. You can also find out about relevant ViewRay Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Radiology
Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...


Corporate Database Quicklinks



Searches Linking to this Company Record